Change of Director Particulars

Summary by AI BETAClose X

Convatec Group Plc announced that Tobias Hestler, a Non-Executive Director, has been appointed to the board of Hikma Pharmaceuticals PLC as a non-executive director, effective August 7, 2026. This announcement is made in accordance with Listing Rule 6.4.9 and does not involve any financial figures for Convatec itself, as the company's 2025 revenues were over $2 billion and it is a constituent of the FTSE 100 Index.

Disclaimer*

Convatec Group PLC
06 August 2026
 

6 August 2026

Convatec Group Plc
("Convatec" or "the Company")

Director Announcement

London, UK, 6 August 2026 - In accordance with Listing Rule 6.4.9, Convatec confirms that Tobias Hestler, Non-Executive Director, has been appointed to the board of Hikma Pharmaceuticals PLC (LSE: HIK) as a non-executive director with effect from 7 August 2026.

Contacts
 Company Secretariat: CoSec@convatec.com 
Media: mediarelations@convatec.com
 Analysts & investors: ir@convatec.com                                                

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

 

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Convatec Group (CTEC)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today